Literature DB >> 29062710

Brucellosis: A cause of meningitis not to neglect.

Abdelhay Lemnouer1, Mohammed Frikh1, Adil Maleb2, Aziz Ahizoune3, Ahmed Bourazza3, Mostafa Elouennass1.   

Abstract

Brucellosis is the most frequent bacteria zoonosis in the world, with more than half a million new cases each year [1]. It is also the most significant zoonos in the edge of the Mediterranean Sea [2]. This zoonosis is capable of affecting humans and cause polymorphic clinical manifestations. In Morocco, the southern regions are the main affected areas [3]. We are reporting the observation of a 17-year-old male patient, who presented a febrile meningeal syndrome for 9 months without sensitivo-motor deficit. Tuberculosis is frequently evoked in such clinical presentations because Morocco is an endemic country, brucellosis is therefore often forgotten. The results of lumbar puncture, magnetic resonance imaging (MRI) and especially serology aided to conclude to a neuro-brucellosis. The outcome was favourable with antibiotic therapy.

Entities:  

Keywords:  Brucellosis; Meningitis; Neurobrucellosis

Year:  2017        PMID: 29062710      PMCID: PMC5645168          DOI: 10.1016/j.idcr.2017.10.001

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Background

Brucellosis is a worldwide zoonosis. It is caused by a bacterium in the genus brucella. The WHO estimates that the infection is responsible for more than 500,000 cases per year across the world [4]. Although the disease has been reported in most countries, the exact number of people affected remains unknown, The WHO considers that the actual incidence is 10–25 times the declared cases [5]. It is endemic in North Africa and remains a public health problem in the Maghreb countries and often underestimated, his epidemiological situation remains unknown [6]. Brucella melitensis biovar 3 is the species responsible for human brucellosis and animal brucellosis mainly small ruminants. In Morocco, seroprevalence in livestock is 1.5%. The most affected regions are the southern of Morocco with a rate between 2.8% to 3, 3% [5]. Brucellosis is characterised by its clinical polymorphism, the involvement of the Central Nervous System (CNS) remains rare and constitutes 4–13%; the meningeal infection is the most common presentation [7]. As tuberculous meningitis is the first diagnosis to be mentioned especially in an endemic country like Morocco, brucellosis is often missed. In Morocco, only a single case has been reported in the literature [5]. Here, we report a second documented case of neurobrucellosis.

Observation

A 17-year-old man, living in a metropolis in the south of the country, with no medical history, was admitted to the emergency ward with complaints of a chronic headache evolving for 9 months with some episodes of vomiting and intermittent fever. There had no visual deficit or limb weakness or balance impairment. He received empiric antibiotic in fever episodes without real improvement. On examination, the patient was conscious, febrile (39 °C) with stiff neck without limb deficit but some brisk reflexes on the lower limbs. Fundus examination was normal. Cerebrospinal fluid (CSF) was at high pressure and showed 90 cells (neutrophils 56%, lymphocytes 44%), proteins 4,11 g/l, glucose 3.06 mg/dl (blood glucose: 108.1 mg/dl). Gram stain was normal. Soluble antigens screen using Wellcozyme Oxoid® eliminated other pathogens of meningitis. CSF GeneXpert investigation was negative excluding mycobacterium tuberculosis complex. CSF culture in blood medium grew brucella melitensis while blood culture (BACTEC™ 960 BC system, Becton-Dickinson) remained negative after 3 weeks of incubation. Blood formula showed haemoglobin of 10 g/dl with normal WBC and platelets, sedimentation rate, electrolytes, kidney and liver testing. CRP was mildly positive at 13.1 mg/l Rose Bengal test (Brucellosis slide BioMerieux® France) was positive in the serum and CSF. CSF Wright test (brucella wright biorad®, France) was positive with a titer of 640. Other serological tests for syphilis, human immunodeficiency virus (HIV), hepatitis B and C virus and Borrelia were negative. Magnetic resonance imaging (MRI) showed evocative signs of a leptomeningitis with meninges thickening especially in posterior cerebral fossa and spinal cone. Thoraco-abdominal computed tomography (CT-Scan) showed lymph nodes in the stomachic coronary chains and the coeco-colo-appendicular regions, and discrete anterior vertebral collapse of the D11 without instability signs. Electroencephalography showed slow spikes in the left temporal lobe. Ophthalmological examination was normal. We concluded to neurobrucellosis diagnosis. The patient was given rifampicin 900 mg/d, doxycycline 200 mg/d for 3months. Clinical and biological outcome was favourable.

Discussion

We reported here what we consider the second case of neurobrucellosis in Morocco. But due to the underestimated incidence of the disease, the lack of reported cases, are likely due to non diagnosed nor declared and then not published ones. Neurological impairment during brucellosis is a rare but serious complication. It occurs in 2–5% of cases [8]. Neurobrucellosis is characterised by a clinical polymorphism. It can mimic all neurological diseases [9]. Meningitis is the most frequent form; it can evolve in an acute or chronic mode [10]. In general, it is more likely to be chronic [11]. This is the case of our patient who presented chronic meningitis evolving for 9 months. The neurological manifestations are various: encephalitis, meningo-encephalitis, meningo-myeloradiculitis or even a psychiatric form [12]. It can sometimes cause a pseudo-tumor with normal CSF. Uncommon cases of neurobrucellosis were described with demyelinisation in adults imitating multiple sclerosis. This form is frequent in adult and has not been seen in children or teenagers [8]. Brucella bacteria may affect the nervous system directly or indirectly, as a result of cytokine or endotoxin effect on the neural tissue. Activation of microglia and cytotoxic T lymphocytes are implicated in the path-physiology of this disease. Infection triggers the immune mechanism leading to demyelinating lesions of brain and spinal cord [13]. The radiological diagnosis of neurobrucellosis is based on the existence of a CNS images not explained by any other neurological disease [14]. Only 45 % of patients affected with neurobrucellosis present radiological abnormalities. The radiological findings can be grouped in 4 categories: (i) Inflammatory lesions: cerebral abscess, granulomas and arachnoiditis, leptomeningeal lesions, basal meningeal or cranial nerves impairments, (ii) White matter impairment with or without demyelinising lesions, (ii) Vascular lesions with chronic ischemic cerebral disease, (iv) Hydrocephalus, cerebral oedema [14]. In our case, brain and spinal cord MRI showed a leptomeningitis of posterior cerebral fossa and spinal cone. In addition, the electroencephalogram revealed a left hemispheric suffering with slow spikes in the left temporal lobe leading to the likely diagnosis of meningo-encephalitis. The impairment of spinal cone was subclinical as patient had no limbs weakness nor bowel or urinary complaints but brisk reflexes on the lower limb. The vertebrae collapse seen in MRI may be the hallmark of spondylitis though patient didn’t complaint of any back pain but he also didn’t report any history of back trauma. Hence, as the patient is young with no morbid conditions, spine involvement by Brucella is the most likely cause of this collapse [15]. In neurobrucellosis, CSF is normal in 84, 6% [12]. Our patient had a clear CSF with a mixed formula of cells, high level of proteins and a low glucose. These findings can fit to diagnosis of tuberculosis especially in our country where tuberculosis is endemic more than brucellosis. But the chronic presentation was against this hypothesis, CNS involvement in tuberculosis being a serious condition that can be lethal if treatment is delayed. Moreover the geneXpert test was negative. Taking into account the epidemiologic data of our patient, as people in south Morocco drink raw camel milk as a custom, and in the patient history, we found that the father has been treated for brucellosis, we had to consider this diagnosis at first and assessed for it. Rose Bengal and Wright’s serum agglutination tests were positive in CSF. These results are in line with literature as serological test in the CSF may be positive in 77% of cases [12]. In addition, CSF culture grew Brucella melitensis but blood culture was negative. Thoraco-abdominal CT-Scan showed lymph nodes in the stomachic coronary chains and appendicular ceco-colic region, which can suggest a digestive source of the contamination [5]. Differential diagnoses of the neurobrucellosis are numerous as the pathogen does not give a typical clinical syndrome or specific modification in the CSF. A large number of investigations usually used in the diagnosis of brucellosis often give negative results [11]. Indeed, false negative results in sero-agglutination tests (SAT) may be obtained in the presence of blocking antibodies or absence of agglutination in low serum dilutions as called prozone phenomenon; Coombs test increases the sensitivity of the SAT [16]. The specificity of blood culture in the diagnosis of brucellosis ranges between 17% and 85%[17]. It was negative in our patient although he had a multiple site involvement. As consequence, the disease must be evoked in all patients who develop unexplained neurological symptoms particularly those who live in endemic areas. In our case, other aetiologies were evoked namely Borreliosis and neurosyphilis that had been excluded by appropriate testing. Treatment of this pathology relies on active antibiotics having good tissue and intracellular diffusion. This treatment must be early and include two to three synergistic and specific antibiotics. They are represented by, cyclines (doxycycline, minocycline), at a dose of 100 to 200 mg per day (adults) associated with Rifampicine at 20 mg/kg/day in children and 600 to 1200 mg/day in adults or an aminoglycoside (streptomycin in particular) for the first 6 weeks of treatment [18]. Other antibiotics such as Amphenicols, Penicillin A and Cotrimoxazole have a questionable activity in vivo.The duration of treatment for neurobrucelosis depends on the stage of the infection. In the secondary forms, notably neuromeningitis, the duration should not be less than 3 months. The rate of relapse is less than 5% [19]. Adding levofloxacin to cycline–rifampin therapy may increase its efficacy in terms of lowering the relapse rate of the disease [20]. Our patient was treated by rifampine 900 mg per day, doxycycline 200 mg per day. The progression was marked by a significant clinical improvement.

Conclusion

Brucellosis is a multi-systemic infection, with a wide range of clinical presentations. Neurobrucellosis is among the most serious forms of the infection. Its clinical symptoms and neuro-radiological signs are usually atypical and can be confused with other neurological diseases that explain the delayed diagnosis and late management. In endemic areas, neurobrucellosis should be considered for any unexplained neurological symptoms.
  15 in total

1.  Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region.

Authors:  Nurgul Ceran; Recai Turkoglu; Ilknur Erdem; Asuman Inan; Derya Engin; Hulya Tireli; Pasa Goktas
Journal:  Braz J Infect Dis       Date:  2011 Jan-Feb       Impact factor: 1.949

2.  Prevalence of bovine and human brucellosis in western Algeria: comparison of screening tests.

Authors:  H Aggad; L Boukraa
Journal:  East Mediterr Health J       Date:  2006 Jan-Mar       Impact factor: 1.628

3.  Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study.

Authors:  Hakan Erdem; Seniha Senbayrak; Kaan Meriç; Ayşe Batirel; Mustafa Kasım Karahocagil; Rodrigo Hasbun; Gonul Sengoz; Hasan Karsen; Selçuk Kaya; Ayşe Seza Inal; Abdullah Umut Pekok; Mustafa Kemal Celen; Secil Deniz; Mehmet Ulug; Tuna Demirdal; Mustafa Namiduru; Recep Tekin; Tumer Guven; Emine Parlak; Sibel Bolukcu; Meltem Avci; Oguz Reşat Sipahi; Derya Ozturk-Engin; Kadriye Yaşar; Filiz Pehlivanoglu; Emel Yilmaz; Selma Ates-Guler; Esmeray Mutlu-Yilmaz; Selma Tosun; Fatma Sirmatel; Elif Sahin-Horasan; Ayhan Akbulut; Nefise Oztoprak; Yasemin Cag; Ayten Kadanali; Huseyin Turgut; Ali Irfan Baran; Hanefi Cem Gul; Mahmut Sunnetcioglu; Asli Haykir-Solay; Affan Denk; Asuman Inan; Celal Ayaz; Asim Ulcay; Sukran Kose; Canan Agalar; Nazif Elaldi
Journal:  Infection       Date:  2016-05-02       Impact factor: 3.553

4.  An unusual case of neurobrucellosis presenting as demyelination disorder.

Authors:  Omer Bektaş; Halil Ozdemir; Arzu Yılmaz; Suat Fitöz; Ergin Ciftçi; Erdal Ince; Erhan Aksoy; Gülhis Deda
Journal:  Turk J Pediatr       Date:  2013 Mar-Apr       Impact factor: 0.552

5.  Could remembering the prozone phenomenon shorten our diagnostic journey in brucellosis? A case of Brucella spondylodiscitis.

Authors:  Gulay Sain Guven; Banu Cakir; Gul Oz; Mine Durusu Tanriover; Ercan Turkmen; Tumay Sozen
Journal:  Rheumatol Int       Date:  2006-02-17       Impact factor: 2.631

Review 6.  Spinal brucellosis: a review.

Authors:  Mouna Chelli Bouaziz; Mohamed Fethi Ladeb; Mohamed Chakroun; Skander Chaabane
Journal:  Skeletal Radiol       Date:  2007-10-26       Impact factor: 2.199

7.  Human brucellosis in Maghreb: existence of a lineage related to socio-historical connections with Europe.

Authors:  Nedjma Lounes; Moulay-Ali Cherfa; Gilles Le Carrou; Abdellah Bouyoucef; Maryne Jay; Bruno Garin-Bastuji; Virginie Mick
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

8.  Neurobrucellosis: A Case Report from Himachal Pradesh, India, and Review of the Literature.

Authors:  Sujeet Raina; Ashish Sharma; Rajesh Sharma; Amit Bhardwaj
Journal:  Case Rep Infect Dis       Date:  2016-10-13

9.  The Diagnostic Value of MRI in Brucella Spondylitis With Comparison to Clinical and Laboratory Findings.

Authors:  Ali Baradaran Bagheri; Koorosh Ahmadi; Niaz Mohamad Jafari Chokan; Bita Abbasi; Reza Akhavan; Ehsan Bolvardi; Somayeh Soroureddin
Journal:  Acta Inform Med       Date:  2016-03-26

10.  A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycycline-rifampin-levofloxacin) for treating acute/subacute brucellosis.

Authors:  Ahmad Hasanain; Reem Mahdy; Asmaa Mohamed; Mostafa Ali
Journal:  Braz J Infect Dis       Date:  2016-04-14       Impact factor: 3.257

View more
  1 in total

1.  Lumbosacral polyradiculitis associated with brucellosis.

Authors:  Fatemeh Sadat Mahdavi; Nahid Abbasi Khoshsirat; Atossa Madanipour
Journal:  IDCases       Date:  2020-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.